Skip to main content
. 2017 Feb;3(2):107–116. doi: 10.1016/j.jacep.2016.04.009

Figure 4.

Figure 4

Cost-Effectiveness Acceptability Curve for Quadripolar Versus Bipolar CRTD

The x-axis shows the willingness-to-pay threshold (i.e., the incremental cost per QALY gained). Quadripolar (Quad) CRTD is 97.1% likely to be cost-effective at £20,000 ($30,000) per QALY gained and 99.3% likely to be cost-effective at £30,000 ($45,000) per QALY gained. Abbreviations as in Figure 2.